Sigba, Juliana R.
HRN: 11-25-97 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
09/11/2023
CO-AMOXICLAV 625MG (TAB)
09/11/2023
09/17/2023
PO
625 Mg Tab, 1 Tab
TID
Cap-MR, Sepsis - (stepdown)
Checking Final Appropriateness
Indication: Empiric Type of Infection: PneumoniaBloodstream Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes